- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 27.03. | FDA to ban electric shock devices for behavior control-again | ||
| 27.03. | 'Transparent mischief' and 'malfeasances' no more: Nymox's legal battle in the Bahamas comes to a close | ||
| 27.03. | Medtronic nets FDA approval for evolved Evolut TAVR valve | ||
| 27.03. | Unable to find a partner for stem cell therapy, Gamida accepts sale to investment firm to survive | ||
| 27.03. | Blackstone bets $750M on Moderna's flu program as approval comes into view | ||
| 27.03. | Altimmune bails on hepatitis B after phase 2 data disappoint, quashing partnering plans | ||
| 26.03. | After terminating 1 of 2 late-stage sickle cell disease trials, Pfizer still expects FDA approval in 2026 | ||
| 26.03. | Abbott nets European approval for 6-year insertable cardiac monitor | ||
| 26.03. | Veeda expands into international markets with Heads acquisition | ||
| 26.03. | Neuronetics' magnetic stimulation cleared as first-line add-on therapy for adolescents with severe depression | ||
| 26.03. | Moderna's next-gen COVID vax surpasses approved version in phase 3 | ||
| 26.03. | Praxis' epilepsy drug hits in phase 2, sparking stock rise and plans for next trial | ||
| 26.03. | Viking sails next-gen oral weight loss drug toward phase 2 after posting 5% weight reduction | ||
| 26.03. | Stoke's shares shoot up 90% as epilepsy drug slashes convulsive seizures | ||
| 26.03. | Ampio prepares to wind down after final therapeutic dream dies | ||
| 25.03. | Report: Every dollar of NIH research funding doubles in economic returns | ||
| 25.03. | Masimo to hive off consumer business, including FDA-cleared baby monitor, health smartwatch | ||
| 25.03. | BD boosts U.S. production as FDA warns against using plastic syringes from China | ||
| 25.03. | Astria's pipeline star reduces hereditary angioedema attacks in early phase 1b/2 data | ||
| 25.03. | AbbVie grabs a wrench to add immunology-focused Landos Biopharma for $137.5M | ||
| 25.03. | FDA blocks approval of Regeneron's blood cancer drug over confirmatory trial enrollment | ||
| 25.03. | Ferrer signs $122M biobucks deal for ex-US license to Verge's phase 1 ALS therapy | ||
| 25.03. | Novo Nordisk inks $1B Cardior buyout to pump up heart failure plans | ||
| 22.03. | In another step forward for AI, UW researchers deliver antibody-generating model | ||
| 22.03. | FDA elevates recall of 6.6M Vyaire Medical emergency bag valve masks |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
